Integrin alpha 4
Integrin alpha 4, encoded by the ITGA9 gene (integrin subunit alpha 9, also known as RLC, ITGA4L and ALPHA-RLC), is an integrin alpha chain that pairs with beta 1 to form a cell-surface adhesion receptor for VCAM1, cytotactin and osteopontin. Browse Assay Genie's current range of Integrin alpha 4 research reagents below, or read on for the biology behind the target.
Integrins are heterodimeric integral membrane glycoproteins made up of an alpha chain and a beta chain, and they mediate both cell-cell and cell-matrix adhesion. Integrin alpha 4 (ITGA9) provides the alpha chain of the integrin alpha-9/beta-1 heterodimer (ITGA9:ITGB1). When bound to the beta 1 chain, it forms a receptor for VCAM1, cytotactin and osteopontin, and it recognises the sequence A-E-I-D-G-I-E-L in cytotactin.
Beyond ligand binding, the ITGA9:ITGB1 integrin has been linked to specific cellular roles. It may play a crucial part in SVEP1/polydom-mediated myoblast cell adhesion. Through its interaction with SVEP1, it also represses PRKCA-mediated L-type voltage-gated channel Ca(2+) influx and ROCK-mediated calcium sensitivity in vascular smooth muscle cells, thereby inhibiting vasocontraction. This makes the receptor a point of interest for studies of adhesion, extracellular matrix recognition and vascular smooth muscle signalling.
The human ITGA9 gene belongs to the HGUC group of integrin alpha subunits and the protein is a member of the integrin alpha chain family. It is a membrane protein. The gene was previously named integrin, alpha 9, and it has also appeared in the literature as RLC, ITGA4L and ALPHA-RLC. A mouse ortholog, Itga9, is recorded. Expression of the gene has been found to be upregulated in small cell lung cancers, which has prompted interest in its role in tumour biology. Researchers working with the Integrin alpha 4 protein or measuring it in experimental systems usually consider it alongside its beta 1 partner and its ligands, since the biological activity described above depends on the assembled heterodimer.
The ITGA9:ITGB1 integrin mediates cell-cell and cell-matrix adhesion and may support SVEP1/polydom-mediated myoblast adhesion.
It acts as a receptor for VCAM1, cytotactin and osteopontin, recognising the A-E-I-D-G-I-E-L sequence in cytotactin.
Via SVEP1, ITGA9:ITGB1 represses L-type channel Ca(2+) influx and ROCK-mediated calcium sensitivity, inhibiting vasocontraction.
Expression of the gene is upregulated in small cell lung cancers, making it relevant to tumour studies.
It is the alpha chain of a heterodimeric integrin that mediates cell-cell and cell-matrix adhesion. Paired with beta 1, it is a receptor for VCAM1, cytotactin and osteopontin, and with SVEP1 it helps inhibit vasocontraction in vascular smooth muscle cells.
The HGNC symbol is ITGA9, with the approved name integrin subunit alpha 9. Aliases and earlier symbols include RLC, ITGA4L and ALPHA-RLC, and the previous name was integrin, alpha 9. UniProt lists the protein as Integrin alpha-9.
The mouse ortholog is Itga9; check the datasheet of any product for its validated reactivity. In human disease, expression of the gene has been found to be upregulated in small cell lung cancers, according to the NCBI Gene summary.
Other integrin alpha subunits, the beta 1 partner chain and ligands or interactors of the ITGA9:ITGB1 receptor.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13797; product specifications from Assay Genie datasheets.